Scarica l'app Stockscreener
5.05
10.30%
-0.58
Pre-mercato:
5.28
0.23
+4.55%
Precedente Chiudi:
$5.63
Aprire:
$5.53
Volume 24 ore:
463.61K
Relative Volume:
0.07
Capitalizzazione di mercato:
$18.61M
Reddito:
$513.90K
Utile/perdita netta:
$-48.50M
Rapporto P/E:
-0.1803
EPS:
-28.0101
Flusso di cassa netto:
$-28.99M
1 W Prestazione:
-18.55%
1M Prestazione:
+99.60%
6M Prestazione:
-64.22%
1 anno Prestazione:
-87.42%
Intervallo 1D:
$5.045
$5.7775
Intervallo di 1 settimana:
$4.3719
$9.12
Portata 52W:
$1.26
$13.54
Co Diagnostics Inc Stock (CODX) Company Profile
Nome
Co Diagnostics Inc
Settore
Industria
Telefono
(801) 438-1036
Indirizzo
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
5.05 | 20.75M | 513.90K | -48.50M | -28.99M | -28.01 |
ABT
Abbott Laboratories
|
90.50 | 158.63B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.53 | 117.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.69 | 104.85B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
48.70 | 72.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.85 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-12 | Downgrade | Sidoti | Buy → Neutral |
| 2021-12-29 | Iniziato | Sidoti | Buy |
| 2021-03-29 | Downgrade | Maxim Group | Buy → Hold |
| 2020-05-20 | Aggiornamento | Maxim Group | Hold → Buy |
| 2020-05-18 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-03 | Downgrade | Maxim Group | Buy → Hold |
Mostra tutto
Co Diagnostics Inc Borsa (CODX) Ultime notizie
OpenAI's Major Overhaul: Aiming for Growth Before IPO - GuruFocus
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C. - Eastern Progress
symbol__ Stock Quote Price and Forecast - CNN
Jane Street Group, LLC's Strategic Acquisition of Co-Diagnostics Inc Shares - GuruFocus
Jane Street entities report 6.4% stake in Co-Diagnostics (CODX) - Stock Titan
Co-Diagnostics (CODX) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Co-Diagnostics advances Ebola PCR test development program - Investing.com UK
Co-Diagnostics (CODX) Advances Ebola PCR Development Program - GuruFocus
Co-Diagnostics advances Ebola PCR test development program By Investing.com - Investing.com South Africa
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities - StreetInsider
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities – Company AnnouncementFT.com - Financial Times
Co-diagnostics(CODX) Stock Options Chain | Quotes & News - Moomoo
Q4 2025 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
Q1 2026 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
[EFFECT] Co-Diagnostics, Inc. SEC Filing - Stock Titan
Is Co-Diagnostics National Security's next diagnostic pick? - MSN
Co-Diagnostics develops Ebola assay strategy following WHO emergency alert (CODX) - MSN
CODX - Finviz
$Co-diagnostics (CODX.US)$ Fuhh... - Moomoo
Co-Diagnostics: Offering Expected to Close on or About May 21 >CODX - Moomoo
Co-Diagnostics (CODX) registers 4.94M shares for resale; up to $5.18M possible - Stock Titan
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - Investing.com
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - MarketBeat
$Co-diagnostics (CODX.US)$ more the boyzzz want - Moomoo
Co-Diagnostics (CODX) Q4 2025 Earnings Transcript - AOL.com
Co-Diagnostics (NASDAQ: CODX) CEO nets RSU shares after tax sale - Stock Titan
Co-Diagnostics (NASDAQ: CODX) CFO reports RSU vesting and tax-related share sale - Stock Titan
Co-Diagnostics (NASDAQ: CODX) president nets RSU shares after tax sale - Stock Titan
Co-Diagnostics (CODX) director receives 1,695-share equity grant - Stock Titan
Director at Co-Diagnostics (NASDAQ: CODX) receives 1,695-share equity grant - Stock Titan
[Form 4] Co-Diagnostics, Inc. Insider Trading Activity - Stock Titan
Co-Diagnostics (NASDAQ: CODX) director awarded 1,695 shares and exercises RSUs - Stock Titan
$Co-diagnostics (CODX.US)$ - Moomoo
Co-Diagnostics (CODX) Enhances PCR Assay Development for Ebola O - GuruFocus
Co-Diagnostics Shares Surge as Investors React to Ebola-test Development Update and Outbreak Headlines - Moomoo
Co-Diagnostics shares surge as investors react to Ebola-test development update and outbreak headlines - Quiver Quantitative
CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over Yet - Yahoo Finance
Co-Diagnostics Advances Ebola Pcr Assay Development Strategy with Joint Venture Cosara - marketscreener.com
21.00 🙏 - Moomoo
CODX Stock Rockets As Saudi Facility And Ebola Assay Shift Outlook - StocksToTrade
Co-Diagnostics stock surges on Ebola test development plan By Investing.com - Investing.com Nigeria
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara - Quantisnow
Co-Diagnostics stock surges on Ebola test development plan - Investing.com
$Co-diagnostics (CODX.US)$ good runner! hope to play yoy again later :) - Moomoo
$Co-diagnostics (CODX.US)$ 🫡 - Moomoo
Point-Of-Care Virus Testing - Trend Hunter
Why Did CODX Stock Nearly Double In Value Today? - Stocktwits
Co-Diagnostics Analyst Ratings and Price Targets | NASDAQ:CODX - Benzinga
Co Diagnostics Inc Azioni (CODX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.07%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):